CSPC Innovation Pharmaceutical Co.,Ltd. — Investor Relations & Filings
CSPC Innovation Pharmaceutical Co., Ltd. focuses on the research, development, production, and distribution of pharmaceutical products and high-end chemical ingredients. The company is a leading global supplier of caffeine and related derivatives, serving the food, beverage, and pharmaceutical sectors. Its product portfolio includes finished dosage forms such as acarbose for the treatment of type 2 diabetes, as well as various functional health products and nutritional supplements. The organization emphasizes technological innovation and quality control in its manufacturing processes, maintaining large-scale production facilities that adhere to international standards. By leveraging advanced chemical synthesis and biotechnology, the company provides essential ingredients and therapeutic solutions to a diverse international clientele, positioning itself as a key player in the global supply chain for specialized pharmaceutical components.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于使用部分闲置募集资金及自有资金进行现金管理的公告 | 2026-03-16 | Chinese | |
| 2025年度独立董事述职报告（李迪斌） | 2026-03-16 | Chinese | |
| 2025年度独立董事述职报告（邸丛枝） | 2026-03-16 | Chinese | |
| 石药创新制药股份有限公司2025年可持续发展报告 | 2026-03-16 | Chinese | |
| 关于2025年度日常关联交易执行情况的公告 | 2026-03-16 | Chinese | |
| 关于召开2025年度股东会的通知 | 2026-03-16 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 38947248 | 关于使用部分闲置募集资金及自有资金进行现金管理的公告 | 2026-03-16 | Chinese | ||
| 38947240 | 2025年度独立董事述职报告（李迪斌） | 2026-03-16 | Chinese | ||
| 38947230 | 2025年度独立董事述职报告（邸丛枝） | 2026-03-16 | Chinese | ||
| 38947215 | 石药创新制药股份有限公司2025年可持续发展报告 | 2026-03-16 | Chinese | ||
| 38946203 | 关于2025年度日常关联交易执行情况的公告 | 2026-03-16 | Chinese | ||
| 38946186 | 关于召开2025年度股东会的通知 | 2026-03-16 | Chinese | ||
| 38946166 | 2025年度非经营性资金占用及其他关联资金往来情况汇总表 | 2026-03-16 | Chinese | ||
| 38946151 | 关于续聘会计师事务所的公告 | 2026-03-16 | Chinese | ||
| 38946138 | 关于2026年度董事、高级管理人员薪酬方案的公告 | 2026-03-16 | Chinese | ||
| 38946125 | 2025年度董事会工作报告 | 2026-03-16 | Chinese | ||
| 38946124 | 2025年度独立董事述职报告（周建平） | 2026-03-16 | Chinese | ||
| 38946114 | 2025年度内部控制审计报告 | 2026-03-16 | Chinese | ||
| 38946102 | 关于计提资产减值准备的公告 | 2026-03-16 | Chinese | ||
| 38946096 | 关于独立董事独立性情况的专项意见 | 2026-03-16 | Chinese | ||
| 38946088 | 2025年度内部控制评价报告 | 2026-03-16 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
CSPC Innovation Pharmaceutical Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55736/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55736 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55736 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55736 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55736}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CSPC Innovation Pharmaceutical Co.,Ltd. (id: 55736)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.